Posts Tagged ‘forums for online pharmacies’

Tadalafil Effective for Urinary Symptoms of Prostatic Hypertrophy

Sunday, January 10th, 2010

Tadalafil (Cialis, Eli Lilly), approved for the treatment of erectile dysfunction (ED), also improves the bladder outlet obstruction index (BOOI) and symptoms of lower urinary tract symptoms in patients with benign prostatic hypertrophy (BPH-LUTS), researchers reported here at the 2009 annual meeting of the American Urological Association.

Results of a study of 200 men aged 40 years and older with BPH-LUTS for at least 6 months and an International Prostate Symptom Score (IPSS) of at least 13 were presented by lead investigator Claus Roehrborn, MD, professor and chair of urology at the University of Texas Southwestern Medical Center in Dallas.

Men were randomly assigned to received tadalafil, 20 mg daily, or placebo for 12 weeks. Subjects were divided into 3 groups according to baseline BOOI: mild (between 13 – 20), moderate (between 20 – 40), and severe (BOOI above 40), and according to LUTS severity: moderate (LUTS below 20) and severe (LUTS score ≥20).

Multiple pressure-flow and free-flow urodynamic measures were taken and IPSS was assessed at follow-up.

After 12 weeks, “…the proportion of obstructed patients in the placebo group increased, while the proportion in the tadalafil group decreased,” Dr. Roehrborn told AUA meeting attendees.

“Relative symptom improvement in IPSS was significantly better for tadalafil than placebo,” he added.

Total IPSS after 12 weeks of tadalafil treatment decreased 4.22 points (P < .001), obstructive symptoms (BOOI) declined 2.83 points (P < .001), and symptoms of bladder irritation decreased 1.39 points (P = .006) compared with placebo.

While Dr. Roehrborn acknowledged that the results were not strongly significant, “…the results of this study indicate that tadalafil 20 mg once daily may have an impact on obstruction.”

AUA spokesperson Ira D. Sharlip, MD, professor of urology at the University of California at San Francisco, told Medscape Urology that “…an improvement of at least 3 points is clinically meaningful,” so that although the statistical numbers were not strongly positive, the clinical implications were.

Childhood Maltreatment Linked to Migraine and Other Pain Disorders

Saturday, January 9th, 2010

http://thumbs.dreamstime.com/thumb_35/1135355885gU6I1H.jpg

January 8, 2010 — A large, new, multicenter survey has found that childhood abuse is highly prevalent among migraine patients and that migraine patients with a history of early-life abuse have significantly more comorbid pain conditions, including irritable bowel syndrome (IBS) and fibromyalgia (FM), compared with those without such a history.

The research appeared in Headache: The Journal of Head and Face Pain, published on behalf of the American Headache Society.

The study, the largest to date to look at early abuse in a migraine population, was conducted by the Women’s Issues Section Research Consortium of the American Headache Society. It included 1348 patients (88% women; mean age, 41 years) with migraine at 11 outpatient headache centers in the United States and Canada.

Using electronic questionnaires, researchers collected sociodemographic information, including age, sex, race, household income, educational level, and substance abuse. They assessed childhood abuse using the Childhood Trauma Questionnaire, a 28-item, self-reported measure of 5 categories of abuse: physical, sexual, and emotional abuse and physical and emotional neglect. Depression was assessed using the Patient Health Questionnaire and anxiety using the Beck Anxiety Inventory.

Headache disorder was determined using the International Classification of Headache Disorders, 2nd Edition, criteria.

Maltreatment Prevalence

The research appeared in 3 separate articles. In the first article, researchers discussed the prevalence of childhood maltreatment. They found that 58% of participants endured childhood abuse or neglect. Emotional abuse was reported most commonly (38%) and in higher severity (12% with “severe to extreme” abuse) than other abuses, such as physical and sexual abuse.

Emotional abuse is “very, very common” in this headache population, said the lead study author, Gretchen E. Tietjen, MD, professor and chair, Department of Neurology, University of Toledo, Ohio. “The rate was higher than previously reported, and it was surprising.”

In population studies, only about 10% of respondents report emotional abuse, she said.

Emotional abuse is relatively difficult to define and has only recently been recognized as a distinct entity, said Dr. Tietjen. This abuse, which can occur on a daily basis and often reflects a poor family environment, may have more dire and long-lasting consequences than other types of abuse.

Neglect, too, has received scant attention in studies even though it is the category of child maltreatment most frequently recorded by child protection agencies.

This part of the study also showed that more than 33% of respondents reported abuse in adulthood, predominantly (70%) between the ages of 18 and 30 years. Physical abuse in adulthood was reported by 20% and sexual abuse by 22%. “From an alternative perspective, of those reporting childhood maltreatment, 43% were revictimized in adulthood,” the study authors write.

Migraine Characteristics

The second article reviewed migraine characteristics and the differences among episodic headache (fewer than 15 headaches a month), frequent headache, and episodic headache that developed into chronic headache. About 40% of participants had migraine with aura, 34% had chronic migraine, and 26% a transformation from episodic to chronic headache.

After adjusting for all variables, including current depression and anxiety, only emotional abuse was associated with chronic migraine (odds ratio, 1.77) and transformational headaches (odds ratio, 1.89). “Having chronic headaches, or a headache all day every day, and transforming from episodic to chronic were tied not as much to the other abuses but to emotional abuse,” said Dr. Tietjen.

Patients who had experienced childhood emotional abuse also tended to develop migraines earlier, at a median of 16 vs 19 years of age for those without such abuse, she said.

Pain Conditions

The third analysis investigated the relationship between childhood abuse and comorbid pain conditions, including IBS, FM, chronic fatigue syndrome (CFS), interstitial cystitis, arthritis, endometriosis, uterine fibroids, and pelvic pain and cramps.

Comorbid pain conditions were common among participants — 25% had arthritis, 31% had IBS, 16% had CFS, and 10% had FM. Some 61% had at least 1 comorbid pain condition, 18% had 2, and 13% had 3 or more pain conditions. Those reporting emotional abuse or physical neglect had significantly more comorbid pain conditions compared with those without these childhood traumas.

“What was interesting and what makes one infer that there may be a causal relationship is the fact that the more severely abused you were and the more different types of abuse you had, the more different pain conditions you had,” said Dr. Tietjen.

The associations of maltreatment and pain were independent of depression and anxiety, both of which were highly prevalent in this population (28% had current depression and 56% had current anxiety). “This suggests that although depression is strongly associated with, and may be a sequela of, childhood maltreatment, emotional abuse and physical neglect each independently contributes to enhanced pain experience,” write the study authors.

From Stress to Headache

What is not clear is how childhood abuse may eventually lead to migraines and other pain conditions. Maltreatment at an early age could cause changes in areas of the brain, including the hippocampus and amygdala, and alter stress responses, said Dr. Tietjen. An alteration in cortisol in childhood “changes forever your stress response,” she noted. These changes may not be evident in childhood but develop over time, she said.

It is impossible to determine how an individual will react to the stress of abuse. It could depend on the severity of abuse, who the abuser was (whether it was a trusted family member or merely an acquaintance), and the age at which the abuse began, said Dr. Tietjen.

It also could depend on genetic makeup. Stress may actually change DNA to make a person more susceptible to the traumatic fallout of abuse. On the other hand, genes may make some people more resilient to the effects of stress.

“It’s probably a very complicated makeup of a lot of different genes and a lot of different things in the environment” that predisposes some people to develop pain and headache after exposure to stress, said Dr. Tietjen.

What might tie abuse and various pain syndromes together is what Dr. Tietjen called “central sensitization,” where stress pushes the central nervous system into overdrive. One of the characteristics of this state of central sensitivity is allodynia. Past research has shown that patients with migraine-related allodynia are more likely to have IBS, CFS, and other pain-related syndromes, said Dr. Tietjen.

Preventing Painful Conditions

However, there may be a way to prevent pain-related manifestations of childhood exposure to abuse. Dr. Tietjen believes that cognitive behavioral therapy, which teaches patients to better handle stress, could prevent painful conditions. She used the example of a 20-year-old woman with a history of abuse who comes in with a migraine. Treating that patient with cognitive behavioral therapy may prevent progression to chronic migraine or prevent FM, IBS, or other conditions that typically develop at a slightly later age.

“Cognitive behavioral therapy might be a good therapy under that circumstance because it changes the body’s response to stress. If you have an abnormal response to stress because of your past experiences, maybe this can help normalize your response.”

According to background information included in the articles, childhood maltreatment is a major public health problem. In the United States, there are nearly 1 million substantiated reports of physical and sexual abuse of children each year. Most reported cases involve neglect, followed by physical abuse then sexual abuse.

Sildenafil citrate

Saturday, January 9th, 2010

http://www.kingston.ac.uk/cps/images/pharmacy-lab-017.jpg
Objective: The aim of this study was to determine the effect of sildenafil on the uterine circulation and clitoral artery blood flow in postmenopausal women using color Doppler sonography.

Methods: The study population consisted of 25 volunteer naturally postmenopausal women (mean age, 50.2 ± 3.6 years). Color Doppler sonography was performed to measure the resistance and pulsatility indexes of the uterine arteries and peak systolic velocity, resistance, and pulsatility indexes of the clitoral arteries. One hour after administration of a single oral dose of 50 mg sildenafil citrate, the Doppler sonographic examination was repeated.

Results: After sildenafil administration, the mean resistance and pulsatility indexes of uterine artery were significantly lower (0.73 ± 0.08 vs 0.80 ± 0.07, P < .001 and 1.66 ± 0.50 vs 2.08 ± 0.52, P < .001, respectively) in comparison to baseline values, and the mean peak systolic velocity of clitoral artery was significantly higher (17.9 ± 8.6 cm/sec vs 12.9 ± 5.8 cm/sec, P < .001). Sildenafil did not cause any significant change in the mean resistance and pulsatility indexes of the clitoral artery (P = .683 and P = .714, respectively).

Conclusion: Sildenafil improves the clitoral and uterine blood flow in healthy postmenopausal women without any erotic stimulus. Further studies are needed to determine whether there are roles for sildenafil therapy in postmenopausal women and evaluation of clitoral blood flow by Doppler sonography.
Introduction

Female sexual dysfunction (FSD) is a multicausal and prevalent problem that can significantly affect the quality of life and interpersonal relationships of postmenopausal women.[1,2] Aging and the decline of ovarian hormonal secretion during the menopausal transition may alter libido and sexual response and functioning.[3-5] This decline relates more to decreasing estradiol concentrations than to androgen levels.[6] In addition to hormonal changes, chronic diseases and medications may also negatively affect vascular response of the end genital organs. Potential therapeutic options for some categories of FSD include hormonal and pharmacologic agents.[7-9] Since nitric oxide (NO) synthase isoforms have been identified in the uterine[10] and clitoral tissues,[11] the NO–cyclic guanosine monophosphate (cGMP) pathway, which is involved in penile erection and enhanced by sildenafil,[12,13] may also play a role in some components of female sexual arousal response. Sildenafil has been demonstrated to be safe and effective in treatment of male erectile dysfunction.[13,14] However, there are little data about the influence of sildenafil on vascular hemodynamics of genital tissues in women. A single randomized placebo-controlled trial of sildenafil treatment for female sexual arousal disorder (FSAD) in postmenopausal women suggests that the agent may be effective for a select population of women (ie, without concomitant lack of sexual desire or contributory emotional, relationship, or historical abuse issues).[15] Pfizer, the company that developed the drug, however, decided against seeking regulatory approval for its use in the treatment of FSAD because several large-scale placebo-controlled studies yielded inconclusive results.[16]

Measuring penile blood flow by color Doppler sonography has become a first-line test for evaluation of erectile dysfunction,[17] which is considered the male analogue to some components of FSAD. Clitoral blood flow measurements by color Doppler sonography may also be a reliable method to assess female sexual response.[18] The purpose of this study was to determine the effect of sildenafil on the uterine circulation and clitoral artery blood flow in postmenopausal women, by color Doppler ultrasound.

wikipedia